A Phase 2b, Open-label Long-term Durability Study of CCH Following Treatment of Edematous Fibrosclerotic Panniculopathy (Cellulite)
Latest Information Update: 15 Oct 2020
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Cellulite
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
Most Recent Events
- 09 Oct 2020 According to an Endo International media release, data from this study will be featured as an oral presentation during the American Society for Dermatologic Surgerys Annual Meeting (ASDS; virtual meeting taking place on 9th to 11th Oct 2020.).
- 04 Aug 2020 Status changed from recruiting to completed.
- 12 May 2020 New trial record